Entre els projectes més rellevants en Covid-19 destaca la participació del VHIR en assaigs clínics per provar l’eficàcia i seguretat de vacunes com ara Janssen, Pfizer-BioNTech en el col·lectiu d’embarassades, i Hipra.

Researchers have detected for the first time that people with type 2 diabetes who have insulin resistance in the myocardium have structural alterations of the heart and more calcifications in the coronary arteries that increase their risk of cardiovascular disease.

The system can rapidly identify viral targets and the expression of viral entry factors, as well as detect inhibitors of viral entry into cells and anti-inflammatory compounds.

The project COCREA SASI. Co creation for the promotion of affective-sexual health from an intercultural perspective has won the award for Best Research Paper.

És el primer cop que s’analitzen totes les cèl·lules que conformen el reservori del VIH a la sang a la vegada, descrivint de quina manera i en quins subtipus de cèl·lules en concret s’ubica aquest reservori en persones que reben tractament antiretroviral

The nurse received this recognition thanks to HEPARJOC-ACTUA, an educational tool to improve the diagnosis of Hepatitis B.

This research has shown the efficacy of dual therapy for HIV treatment, with dolutegravir and lamivudine, compared with the standard treatment with three drugs.

Vall d’Hebron University Hospital diagnosed the first case of HIV in Spain in October 1981. This was a 35 year-old man who was admitted to hospital with Kaposi’s sarcoma and other opportunistic infections.

The Unit of Tropical Medicine and International Health in Vall d'Hebron works in different projects to promote research and training in Angola since 2007.

The program, promoted by Biocat in collaboration with CIMIT (Boston), is aimed at entrepreneurs in the process of bringing their technology to market in the next few years.

The colloquium has been coordinated and moderated by Dr. Joan X. Comella and Dr. Fernando Salvador. Dr. Pau Bosch also participated.

Researchers have found lung-resident memory T lymphocytes months after SARS-CoV-2 infection, which would rapidly activate in the event of possible reinfection.